Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bin Su

Showing results (1031-1040 of 1,052) with videos related to

Pageof 106
Sort By:
Plos One|February 14, 2013
HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patientsHui Xing, Yuhua Ruan, Jingyun Li, et al.
Infectious Diseases of Poverty|August 14, 2023
Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysisXinsheng Wu, Guohui Wu, Ping Ma, et al.
The Lancet Regional Health. Western Pacific|August 7, 2023
Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96Bin Su, Guiju Gao, Min Wang, et al.
JMIR Research Protocols|May 29, 2023
Voluntary Medical Male Circumcision and Incident HIV Infection Among Men Who Have Sex With Men in China (The CoM Study): Protocol for a Randomized Controlled TrialYanxiao Gao, Weiran Zheng, Yinghui Sun, et al.
Mabs|January 13, 2010
Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41Donna L Montgomery, Ying-Jie Wang, Renee Hrin, et al.
Annals of Internal Medicine|May 27, 2024
Efficacy of Voluntary Medical Male Circumcision to Prevent HIV Infection Among Men Who Have Sex With Men : A Randomized Controlled TrialYanxiao Gao, Yuewei Zhan, Yinghui Sun, et al.
Science Advances|September 17, 2020
A V<sub>H</sub>1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersiteSonu Kumar, Bin Ju, Benjamin Shapero, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 19, 2011
[Immunogenicity and safety of DTaP-IPV//PRP-T combined vaccine in infants in China]Yan-ping Li, Feng-xiang Li, Qi-ming Hou, et al.
Vaccine|October 18, 2011
Antibody persistence at 18-20 months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of ChinaRong Cheng Li, Feng Xiang Li, Yan Ping Li, et al.
Vaccine|January 12, 2011
Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in ChinaRong Cheng Li, Feng Xiang Li, Yan Ping Li, et al.
Pageof 106

Showing results (1031-1040 of 1,052) with videos related to

Sort By:
Pageof 106
Plos One|February 14, 2013
HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patientsHui Xing, Yuhua Ruan, Jingyun Li, et al.
Infectious Diseases of Poverty|August 14, 2023
Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysisXinsheng Wu, Guohui Wu, Ping Ma, et al.
The Lancet Regional Health. Western Pacific|August 7, 2023
Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96Bin Su, Guiju Gao, Min Wang, et al.
JMIR Research Protocols|May 29, 2023
Voluntary Medical Male Circumcision and Incident HIV Infection Among Men Who Have Sex With Men in China (The CoM Study): Protocol for a Randomized Controlled TrialYanxiao Gao, Weiran Zheng, Yinghui Sun, et al.
Mabs|January 13, 2010
Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41Donna L Montgomery, Ying-Jie Wang, Renee Hrin, et al.
Annals of Internal Medicine|May 27, 2024
Efficacy of Voluntary Medical Male Circumcision to Prevent HIV Infection Among Men Who Have Sex With Men : A Randomized Controlled TrialYanxiao Gao, Yuewei Zhan, Yinghui Sun, et al.
Science Advances|September 17, 2020
A V<sub>H</sub>1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersiteSonu Kumar, Bin Ju, Benjamin Shapero, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 19, 2011
[Immunogenicity and safety of DTaP-IPV//PRP-T combined vaccine in infants in China]Yan-ping Li, Feng-xiang Li, Qi-ming Hou, et al.
Vaccine|October 18, 2011
Antibody persistence at 18-20 months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRP∼T vaccine compared to separate vaccines (DTaP, PRP∼T and IPV) following primary vaccination of healthy infants in the People's Republic of ChinaRong Cheng Li, Feng Xiang Li, Yan Ping Li, et al.
Vaccine|January 12, 2011
Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in ChinaRong Cheng Li, Feng Xiang Li, Yan Ping Li, et al.
Pageof 106